Skip to main content
Log in

18F-FDG/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis

  • Case Presentation Corner
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

18F-flurodeoxyglycose (FDG)/13N-ammonia positron emission tomography/computed tomography (PET/CT) is frequently utilized to evaluate cardiac sarcoidosis (CS) but findings can reflect other forms of myocardial inflammation or altered myocardial metabolic activity. Herein, we present five cases where cardiac PET findings suggested CS, but right ventricular endomyocardial biopsy samples revealed ATTR-type cardiac amyloidosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Abbreviations

ATTR-CM:

Transthyretin amyloid cardiomyopathy

CMR:

Cardiac magnetic resonance imaging

CS:

Cardiac sarcoidosis

EF:

Ejection fraction

EMBx:

Endomyocardial biopsy

18F-FDG:

18F-flurodeoxyglycose

GLS:

Global longitudinal strain

H/CL:

Heart to contralateral lung

LC-MS/MS:

Liquid chromatography-tandem mass spectrometry

LV:

Left ventricular

PET/CT:

Positron emission tomography/computed tomography

PVC:

Premature ventricular contraction

PYP:

99MTechnetium-pyrophosphate

SPECT/CT:

Single photon emission computed tomography/computed tomography

TTE:

Transthoracic echocardiogram

TTR:

Transthyretin

VT:

Ventricular tachycardia

References

  1. Bois JP, Muser D, Chareonthaitawee P. PET/CT evaluation of cardiac sarcoidosis. PET Clin 2019;14:223‐32.

    Article  PubMed  Google Scholar 

  2. Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL. Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med 2017;58:1341‐53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305‐23.

    Article  PubMed  Google Scholar 

  4. Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis-digest version. Circ J 2019;83:2329‐88.

    Article  PubMed  Google Scholar 

  5. Elwazir MY, Bois JP, Abou Ezzeddine OF, Chareonthaitawee P. Imaging and quantification of cardiac sarcoidosis. Semin Nucl Med 2020;50:283‐94.

    Article  PubMed  Google Scholar 

  6. Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 2019;73:2872‐91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Dasari S, Theis JD, Vrana JA, Rech KL, Dao LN, Howard MT, et al. Amyloid typing by mass spectrometry in clinical practice: A comprehensive review of 16,175 samples. Mayo Clin Proc 2020;95:1852‐64.

    Article  CAS  PubMed  Google Scholar 

  8. Vaidya VR, Abudan AA, Vasudevan K, Shantha G, Cooper LT, Kapa S, et al. The efficacy and safety of electroanatomic mapping-guided endomyocardial biopsy: A systematic review. J Interv Card Electrophysiol 2018;53:63‐71.

    Article  PubMed  Google Scholar 

  9. Mohammed SF, Mirzoyev SA, Edwards WD, Dogan A, Grogan DR, Dunlay SM, et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2014;2:113‐22.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Siegismund CS, Escher F, Lassner D, Kuhl U, Gross U, Fruhwald F, et al. Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis. Eur J Heart Fail 2018;20:751‐7.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No funding support for this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John P. Bois MD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Young, K.A., Lyle, M., Rosenbaum, A.N. et al. 18F-FDG/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis. J. Nucl. Cardiol. 30, 726–735 (2023). https://doi.org/10.1007/s12350-021-02886-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-021-02886-2

Keywords

Navigation